Table 2.
Physician Characteristics by Physician Practice Type
| Solo | Group | Missing | |||
|---|---|---|---|---|---|
| Mean (Standard Deviation) or n (%) | p-value | ||||
| N=462 | N=1,545 | N=131 | |||
| Mean Primary GnRH agonist Use 2000–2007 (SD) | 0.3 (0.3) | 0.2 (0.3) | 0.1 (0.2) | <0.001 | |
| Time in Practice | 385 (29.5%) | 879 (67.4%) | 41 (3.1%) | <0.001 | |
| Male* | 1–5* (5–10%) | 41 (83.7%) | 5–10* (10–15%) | <0.001 | |
| Board Certified | 407 (20.4%) | 1,471 (73.8%) | 115 (5.8%) | <0.001 | |
| US Trained | 330 (18.4%) | 1,349 (75.0%) | 119 (6.6%) | <0.001 | |
| Medical School Affiliation | <0.001 | ||||
| None | 258 (27.2%) | 639 (67.4%) | 51 (5.4%) | ||
| Some | 192(16.6%) | 886 (76.7%) | 77 (6.7%) | ||
| Missing* | 10–15* (30–35%) | 20 (57.1%) | 1–5* (5–10%) | ||
| Physician Prostate Panel Size (prostate patients/year) | <0.001 | ||||
| 0–20 | 302 (26.2%) | 768 (66.6%) | 83 (7.2%) | ||
| 21–37 | 119 (18.3%) | 498 (76.5%) | 34 (5.2%) | ||
| ≥38 | 41 (12.3%) | 279 (83.5%) | 14 (4.2%) | ||
| Proportion Patients Minority | <0.001 | ||||
| 0%–6.1% | 146 (18.8%) | 582 (75.1%) | 47 (6.1%) | ||
| 6.2%–19.5% | 110 (18.4%) | 457 (76.6%) | 30 (5.0%) | ||
| ≥20.0% | 206 (26.9%) | 506 (66.1%) | 54 (7.1%) | ||
N=2,138
P-values by t-test for continuous variables, chi2 test for binary/categorical variables; time invariant physician measures described at first entry into cohort
*
Exact count masked to protect subject confidentiality, per Data Use Agreement